Jacques Fantini
#160,459
Most Influential Person Now
Researcher
Jacques Fantini's AcademicInfluence.com Rankings
Jacques Fantinibiology Degrees
Biology
#12675
World Rank
#16166
Historical Rank
Molecular Biology
#2081
World Rank
#2113
Historical Rank
Neuroscience
#2142
World Rank
#2202
Historical Rank
Biochemistry
#2179
World Rank
#2324
Historical Rank

Download Badge
Biology
Jacques Fantini's Degrees
- PhD Neuroscience Université Paris Cité
Why Is Jacques Fantini Influential?
(Suggest an Edit or Addition)Jacques Fantini's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection (2020) (434)
- How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains (2013) (370)
- CH-π hydrogen bonds in biological macromolecules. (2014) (307)
- Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. (1993) (249)
- Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells (1992) (239)
- Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 Proteins* (2002) (223)
- Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases (2002) (220)
- The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells. (2002) (220)
- Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. (2009) (209)
- The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. (2002) (197)
- Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor (2011) (191)
- Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. (2010) (166)
- Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases (2010) (162)
- Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. (2008) (147)
- Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation. (2014) (137)
- Specific Interaction of HIV-1 and HIV-2 Surface Envelope Glycoproteins with Monolayers of Galactosylceramide and Ganglioside GM3* (1998) (134)
- Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein (2016) (128)
- Human Erythrocyte Glycosphingolipids as Alternative Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1) Entry: Evidence for CD4-Induced Interactions between HIV-1 gp120 and Reconstituted Membrane Microdomains of Glycosphingolipids (Gb3 and GM3) (1999) (128)
- Mutation Patterns of the Reverse Transcriptase and Protease Genes in Human Immunodeficiency Virus Type 1-Infected Patients Undergoing Combination Therapy: Survey of 787 Sequences (1999) (114)
- The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain. (2011) (113)
- Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. (1986) (111)
- Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. (1994) (110)
- Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. (2011) (108)
- Synthetic Soluble Analogs of Galactosylceramide (GalCer) Bind to the V3 Domain of HIV-1 gp120 and Inhibit HIV-1-induced Fusion and Entry* (1997) (107)
- How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's β Amyloid Peptide (Aβ1-40) (2010) (104)
- A mirror code for protein-cholesterol interactions in the two leaflets of biological membranes (2016) (100)
- Co‐expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT‐29 (1997) (97)
- Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997–2002) based on an analysis of over 7000 genotypes (2003) (93)
- Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation (2013) (92)
- Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4. (1989) (91)
- How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains (2003) (91)
- Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. (1991) (83)
- Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. (1994) (82)
- The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. (2001) (82)
- Mechanism of cholesterol‐assisted oligomeric channel formation by a short Alzheimer β‐amyloid peptide (2014) (82)
- Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. (2005) (78)
- The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. (2009) (77)
- Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide. (2013) (73)
- Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line (1995) (72)
- Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal (2020) (72)
- Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model. (2004) (71)
- Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion (2000) (67)
- Prediction of glycolipid-binding domains from the amino acid sequence of lipid raft-associated proteins: application to HpaA, a protein involved in the adhesion of Helicobacter pylori to gastrointestinal cells. (2006) (67)
- Quantification of HIV‐1 viral load in lymphoid and blood cells: assessment during four‐drug combination therapy (1997) (65)
- A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interaction DOI 10.1194/jlr.M200165-JLR200 (2002) (65)
- A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection (2006) (65)
- Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks (2021) (65)
- Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signal transduction pathways and perturbations of intestinal absorption and secretion (2000) (64)
- Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor. (2006) (64)
- Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations. (2000) (64)
- The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains. (2013) (64)
- The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand (2008) (63)
- The puzzling mutational landscape of the SARS‐2‐variant Omicron (2022) (63)
- Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. (2010) (63)
- Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides. (2014) (62)
- SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. (1996) (62)
- Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) domains. (2016) (62)
- The virotoxin model of HIV-1 enteropathy: involvement of GPR15/Bob and galactosylceramide in the cytopathic effects induced by HIV-1 gp120 in the HT-29-D4 intestinal cell line. (2003) (61)
- Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29‐D4 cells (1989) (58)
- Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29). (1985) (57)
- Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion (1992) (57)
- Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. (2001) (56)
- Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. (1998) (55)
- Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria? (2008) (54)
- Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells. (1998) (54)
- A Unifying Theory (2015) (54)
- The Insertion and Transport of Anandamide in Synthetic Lipid Membranes Are Both Cholesterol-Dependent (2009) (53)
- Metabolic changes in undifferentiated and differentiated human colon adenocarcinoma cells studied by multinuclear magnetic resonance spectroscopy. (1989) (51)
- Cholesterol-Recognition Motifs in Membrane Proteins. (2019) (51)
- Culture and identification of a “Deltamicron” SARS‐CoV‐2 in a three cases cluster in southern France (2022) (50)
- Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy. (1997) (49)
- Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. (2001) (48)
- Suramin inhibits proliferation of rat glioma cells and alters N‐cam cell surface expression (1990) (48)
- Rafts and related glycosphingolipid-enriched microdomains in the intestinal epithelium: bacterial targets linked to nutrient absorption. (2004) (48)
- Notch ligand activity is modulated by glycosphingolipid membrane composition in Drosophila melanogaster (2010) (47)
- The minimal amyloid‐forming fragment of the islet amyloid polypeptide is a glycolipid‐binding domain (2006) (47)
- Production of insulin‐like growth factor II (IGF‐II) and different forms of IGF‐binding proteins by HT‐29 human colon carcinoma cell line (1990) (47)
- Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19 (2020) (46)
- Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth. (1992) (45)
- Relevance of CARC and CRAC Cholesterol-Recognition Motifs in the Nicotinic Acetylcholine Receptor and Other Membrane-Bound Receptors. (2017) (44)
- Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide (2014) (44)
- A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. (2002) (44)
- Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications. (2007) (42)
- Brain Lipids in Synaptic Function and Neurological Disease: Clues to Innovative Therapeutic Strategies for Brain Disorders (2015) (42)
- Intracellular calcium release induced by human immunodeficiency virus type 1 (HIV-1) surface envelope glycoprotein in human intestinal epithelial cells: a putative mechanism for HIV-1 enteropathy. (1995) (42)
- Stable rearrangements of the β3–β4 hairpin loop of HIV‐1 reverse transcriptase in plasma viruses from patients receiving combination therapy (1998) (42)
- Controlled aggregation of adenine by sugars: physicochemical studies, molecular modelling simulations of sugar-aromatic CH-pi stacking interactions, and biological significance. (2008) (37)
- Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages (1994) (37)
- SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms. (1995) (37)
- Mutation L210W of HIV-1 reverse transcriptase in patients receiving combination therapy. Incidence, association with other mutations, and effects on the structure of mutated reverse transcriptase. (2000) (36)
- Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination? (2021) (36)
- The Development of Na+-dependent Glucose Transport during Differentiation of an Intestinal Epithelial Cell Clone Is Regulated by Protein Kinase C (*) (1995) (35)
- Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry. (2008) (34)
- Sphingolipid-binding domain in the serotonin(1A) receptor. (2012) (33)
- Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells. (1991) (33)
- Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter (2018) (32)
- Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers? (2020) (32)
- Emergence in Southern France of a new SARS-CoV-2 variant of probably Cameroonian origin harbouring both substitutions N501Y and E484K in the spike protein (2021) (30)
- Glycolipids as potential binding sites for HIV: topology in the sperm plasma membrane in relation to the regulation of membrane fusion. (1998) (29)
- In vitro differentiated HT 29‐D4 clonal cell line generates leakproof and electrically active monolayers when cultured in porous‐bottom culture dishes (1989) (28)
- pH-dependent interaction of fumonisin B1 with cholesterol: physicochemical and molecular modeling studies at the air-water interface. (2002) (28)
- Biophysical studies of the interaction of squalamine and other cationic amphiphilic molecules with bacterial and eukaryotic membranes: importance of the distribution coefficient in membrane selectivity. (2010) (28)
- Comparison of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Mutations in HIV-1 Genomes Detected in Plasma and in Peripheral Blood Mononuclear Cells from Patients Receiving Combination Drug Therapy (1999) (27)
- The combinatorial extension method reveals a sphingolipid binding domain on pancreatic bile salt-dependent lipase: role in secretion. (2004) (27)
- Apical uptake and transepithelial transport of sphingosine monomers through intact human intestinal epithelial cells: physicochemical and molecular modeling studies. (2005) (27)
- Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B (2019) (27)
- From hopanoids to cholesterol: Molecular clocks of pentameric ligand-gated ion channels. (2016) (27)
- Genetic analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variant. (2001) (26)
- Intestinal absorption of the acetamiprid neonicotinoid by Caco-2 cells: Transepithelial transport, cellular uptake and efflux (2008) (25)
- Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis. (1999) (25)
- A cholesterol recognition motif in human phospholipid scramblase 1. (2014) (24)
- HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infection. (1998) (24)
- Interferon-γ Decreases Cell Surface Expression of Galactosyl Ceramide, the Receptor for HIV-1 GP120 on Human Colonic Epithelial Cells (1994) (23)
- Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free medium. (1990) (23)
- The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature. (1987) (23)
- Perturbations of glucose metabolism associated with HIV infection in human intestinal epithelial cells: a multinuclear magnetic resonance spectroscopy study (1997) (23)
- Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4). (1988) (23)
- Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma (2012) (23)
- Characterization of an electrogenic sodium/glucose cotransporter in a human colon epithelial cell line (1995) (22)
- Asymmetric Synthesis of Water‐Soluble Analogues of Galactosylceramide, an HIV‐1 Receptor: New Tools to Study Virus–Glycolipid Interactions (2002) (22)
- C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120. (2006) (20)
- Hybrid In Silico/In Vitro Approaches for the Identification of Functional Cholesterol-Binding Domains in Membrane Proteins. (2017) (20)
- Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide. (2000) (20)
- Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose. (1990) (19)
- Intracellular localisation of suramin, an anticancer drug, in human colon adenocarcinoma cells: a study by quantitative autoradiography. (1996) (19)
- Replication and apical budding of HIV-1 in mucous-secreting colonic epithelial cells. (1992) (19)
- Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. (2020) (19)
- Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides. (2016) (18)
- Synthesis of single- and double-chain fluorocarbon and hydrocarbon galactosyl amphiphiles and their anti-HIV-1 activity. (2000) (18)
- First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France (2022) (18)
- Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactions. (2000) (17)
- A Glycosphingolipid Binding Domain Controls Trafficking and Activity of the Mammalian Notch Ligand Delta-Like 1 (2013) (17)
- Characterization of galactosyl glycerolipids in the HT29 human colon carcinoma cell line. (2001) (17)
- Evaluation of the effect of suramin on neural cell growth and N-CAM expression. (1990) (17)
- Structural analysis of reverse transcriptase mutations at codon 215 explains the predominance of T215Y over T215F in HIV-1 variants selected under antiretroviral therapy. (2005) (16)
- High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2 (2021) (16)
- Amphiphilic anionic analogues of galactosylceramide: synthesis, anti-HIV-1 activity, and gp120 binding. (2001) (16)
- GalCer, CD26 and HIV infection of intestinal epithelial cells. (1994) (16)
- Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease (2021) (15)
- Analysis of individual purine and pyrimidine nucleoside di‐ and triphosphates and other cellular metabolites in PCA extracts by using multinuclear high resolution NMR spectroscopy (1996) (15)
- The Virotoxin Model of HIV-1 Enteropathy: Involvement of GPR15/Bob and Galactosylceramide in the Cytopathic Effects Induced by HIV-1 gp120 in the HT-29-D4 Intestinal Cell Line (2003) (15)
- The glycosphingolipid MacCer promotes synaptic bouton formation in Drosophila by interacting with Wnt (2018) (14)
- A new method for the determination of specific 13C enrichment in phosphorylated [1-13C]glucose metabolites. 13C-coupled, 1H-decoupled 31P-NMR spectroscopy of tissue perchloric acid extracts. (1996) (14)
- Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein (2022) (14)
- HIV-1 transmission across the vaginal epithelium. (1997) (14)
- Synthetic soluble analogs of glycolipids for studies of virus-glycolipid interactions. (2000) (13)
- Mutations in HIV-1 gag cleavage sites and their association with protease mutations. (2001) (13)
- Mapping of Domains on HIV Envelope Protein Mediating Association with Calnexin and Protein-disulfide Isomerase* (2010) (13)
- Inhibition of human immunodeficiency virus infection in human colon epithelial cells by recombinant interferon‐γ (1992) (13)
- Double screening of suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic agents with reduced toxicity. (1991) (13)
- Suramin : a molecule with a broad spectrum of biological and therapeutic properties (1997) (12)
- Energetic metabolism of glucose, mannose and galactose in glucose-starved rat insulinoma cells anchored on microcarrier beads. A phosphorus-31 NMR study. (1992) (12)
- Non-lipolytic and lipolytic sequence-related carboxylesterases: a comparative study of the structure-function relationships of rabbit liver esterase 1 and bovine pancreatic bile-salt-activated lipase. (2010) (12)
- Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on human colonic epithelial cells. (1994) (12)
- Effect of vip on the glycogen metabolism of human colon adenocarcinoma cells studied by 13C nuclear magnetic resonance spectroscopy (1990) (11)
- Monensin and tunicamycin-induced inhibition of HT29 cell spreading and growth. (1986) (11)
- Selective transport of staphylococcal enterotoxin A through in vitro generated human M cells. (2007) (11)
- Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity. (1991) (10)
- Phosphorus-31 nuclear magnetic resonance study of the C6 glioma cell line cultured on microcarrier beads (1989) (10)
- Ganglioside binding domains in proteins: Physiological and pathological mechanisms. (2022) (10)
- Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes (2022) (10)
- Multi-branched peptides based on the HIV-1 V3 loop consensus motif inhibit HIV-1 and HIV-2 infection in CD4+ and CD4- cells. (1993) (9)
- Physical contact with lymphocytes is required for reactivation of dormant HIV-1 in colonic epithelial cells: involvement of the HIV-1 LTR. (1994) (9)
- Characterization of the vasoactive intestinal peptide (VIP) binding sites: A biochemical and an immunological approach (1986) (9)
- Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors. (1987) (9)
- Tumor necrosis factor-alpha stimulates both apical and basal production of HIV in polarized human intestinal HT29 cells. (1992) (9)
- A suramin derivative induces enterocyte‐like differentiation of human colon cancer cells without lysosomal storage disorder (1990) (8)
- The Glycoprotein Nature of the Vasoactive Intestinal Peptide Binding Site. Role of Carbohydrates in VIP Binding on HT 29‐D4 Cells a (1988) (8)
- A synthetic amino acid substitution of Tyr10 in Aβ peptide sequence yields a dominant negative variant in amyloidogenesis (2012) (8)
- Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase. (2001) (8)
- Aβ Behavior on Neuronal Membranes: Aggregation and Toxicities (2011) (8)
- CD4 molecules are restricted to the basolateral membrane domain of in vitro differentiated human colon cancer cells (HT29‐D4) (1990) (8)
- Total synthesis of mololipids: a new series of anti-HIV Moloka'iamine derivatives. (2000) (8)
- Vectorial release of carcinoembryonic antigen induced by IFN-gamma in human colon cancer cells cultured in serum-free medium. (1991) (8)
- Anandamide-ceramide interactions in a membrane environment: Molecular dynamic simulations data (2017) (8)
- Kinetics of biochemical, electrophysiological and morphological events (including lysosomal disorder) during the course of suramin‐induced differentiation of the human colon‐cancer cell clone HT29‐D4 (1991) (8)
- Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells. (2017) (8)
- Interaction of cholesterol with sphingosine Published, JLR Papers in Press, November 1, 2004. DOI 10.1194/jlr.M400199-JLR200 (2005) (7)
- Gene Therapy Strategy for Alzheimer’s and Parkinson’s Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells (2021) (7)
- Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides. (2011) (7)
- The concentration of glucose in the culture medium determines the effect of suramin on the growth and differentiation of the human colonic adenocarcinoma cell clone HT29-D4. (1990) (7)
- Endocannabinoids tune intrinsic excitability in O-LM interneurons by direct modulation of post-synaptic Kv7 channels. (2021) (7)
- Short‐term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29‐D4 cells (1992) (7)
- Autoradiographic localization of tritiated suramin in polarized human colon adenocarcinoma cells. (1993) (7)
- The epigenetic dimension of protein structure (2022) (6)
- Genetic determinants controlling HIV-1 tropism for CD4-/GalCer+ human intestinal epithelial cells (1996) (6)
- The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program (2022) (6)
- Chapter 7 – Lipid Regulation of Receptor Function (2015) (6)
- Impaired carcinoembryonic antigen release during the process of suramin‐induced differentiation of the human colic adenocarcinoma cell clone HT29‐D4 (1990) (6)
- Common Mechanisms in Neurodegenerative Diseases (2015) (5)
- Differentiation in human colon tumor cells. Importance of autocrine growth factors (1992) (5)
- V3 loop-derived multibranched peptides as inhibitors of HIV infection in CD4+ and CD4− cells (1996) (5)
- How membrane lipids control the 3D structure and function of receptors (2018) (5)
- Infection of HIV-1 and HIV-2 through the luminal and serosal sides of polarized human intestinal epithelial cells. (1992) (5)
- Protein–Lipid Interactions in the Brain (2015) (5)
- Comparison of the amyloid pore forming properties of rat and human Alzheimer’s beta-amyloid peptide 1-42: Calcium imaging data (2016) (5)
- Cellular isoform of the prion protein PrPc in human intestinal cell lines: Genetic polymorphism at codon 129, mRNA quantification and protein detection in lipid rafts (2006) (5)
- Growth in serum-free medium of human colonic adenocarcinoma cell lines on microcarriers: A two-step method allowing optimal cell spreading and growth (1987) (4)
- A Vaccine Strategy Based on the Identification of an Annular Ganglioside Binding Motif in Monkeypox Virus Protein E8L (2022) (4)
- Evidence for an ectophosvitin kinase activity that phosphorylates a 123 kDa endogenous substrate on a human colonic adenocarcinoma cell (HT 29). (1987) (4)
- The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans. (2022) (4)
- The emergence, spread and vanishing of a French SARS‐CoV‐2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule (2022) (4)
- Therapeutic Strategies for Neurodegenerative Diseases (2015) (4)
- Mutation L210W of HIV-1 Reverse Transcriptase in Patients Receiving Combination Therapy (2000) (3)
- AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery (2022) (3)
- The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Black Queen rule (2022) (3)
- Mechanisms of insulin action: by P. Belfrage, J. Donner and P. Stralfors. Elsevier/Fernström Foundations Series, Amsterdam, 1986, pp. 409, US$ 101.75 (1987) (3)
- Structural variability ofenv andgag gene products from a highly cytopathic strain of HIV-1 (2005) (3)
- Secondary structure predictions of HIV-1 reverse transcriptase provide new insights into the development of drug-resistance genotypes. (2001) (3)
- Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France (2022) (3)
- Role of spike compensatory mutations in the interspecies transmission of SARS-CoV-2 (2022) (3)
- Co-localization of suramin and serum albumin in lysosomes of suramin-treated human colon cancer cells. (1996) (3)
- Production of a highly cytopathic HIV-1 isolate from a human mucosal epithelial cell line cultured on microcarrier beads in serum-free medium (2007) (2)
- [The intestinal immune system. The VIP receptor on T lymphocytes: a new marker of differentiation?]. (1985) (2)
- First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco (2022) (2)
- Suramin: A polysulfonated compound that inhibits the binding of HIV-1 gp120 to GalCer/sulfatide and blocks the CD4-independent pathway of HIV-1 infection in mucosal epithelial cells (1996) (2)
- Lipid Metabolism and Oxidation in Neurons and Glial Cells (2015) (2)
- Detection of functional galactosylceramide (GalCer) receptors on CD4-negative HIV-1 target cells (1996) (2)
- SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects (2022) (2)
- Galactosylceramide and transmembrane signalling in enterocytes: Calcium response induced by HIV-1 surface-envelope glycoprotein gp120 (1996) (1)
- Biochemical and immunological approaches of the characterization of vasoactive intestinal peptide (VIP) receptors (1985) (1)
- Chemical Basis of Lipid Biochemistry (2015) (1)
- Combination of culture on collagen gels and glucose starvation for cloning human colon cancer cells (1991) (1)
- AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer’s Disease Therapy (2023) (1)
- Humanimmunodeficiency virus caninfect theapical and basolateral surfaces ofhumancolonic epithelial cells (1991) (1)
- Inhibition of human immunodeficiency virus infection in human colon epithelial cells by recombinant interferon-gamma. (1992) (1)
- Variations of Brain Lipid Content (2015) (1)
- Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines. (1991) (1)
- Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors (2023) (1)
- Chapter 11 – Alzheimer’s Disease (2015) (1)
- Review for "Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis" (2020) (0)
- [The in vitro differentiation of cancer cells of the human colon (HT29-D4) is associated with the presence of annulate lamellae in the basal part of the cytoplasm]. (1990) (0)
- Structural Basis of Botulinum Toxin Type F Binding to Glycosylated Human SV2A: In Silico Studies at the Periphery of a Lipid Raft (2022) (0)
- Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era (2023) (0)
- Chapter 2 – Brain Membranes (2015) (0)
- Contents Vol. 7, 2000 (2000) (0)
- Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future (2023) (0)
- All-atom Molecular Dynamics Simulation of botulinum neurotoxin serotype A1 in complex with human SV2A or SV2C receptors in a lipid raft environment (2022) (0)
- A New Putative Cholesterol-Recognition Motif in Transmembrane Proteins (2012) (0)
- Viral and Bacterial Diseases (2015) (0)
- A Molecular View of the Synapse (2015) (0)
- Polarized distribution of γ interferon-stimulated MHC antigens and transferrin receptors in a clonal cell line isolated from Fisher rat thyroid (FRT cells) (1993) (0)
- Special lectures VIII. AIDS. (1992) (0)
- Review for "The Structural Basis of Accelerated Host Cell Entry by SARS‐CoV‐2 †" (2020) (0)
- SPC3, a nontoxic peptide inhibitor of HIV infection (1995) (0)
- A study of viral populations by sequencing analysis of pol gene under triple combination therapy given at the time of primary HIV-1 infection (1999) (0)
- A synthetic amino acid substitution of Tyr10 in Abeta peptide sequence acts as a dominant negative in amyloidogenesis (2011) (0)
- Long-lasting reduction of intrinsic excitability in O-LM interneurons is mediated by endocannabinoid-dependent up-regulation of Kv7 channels (2021) (0)
- Alternative Receptors for HIV-1 in Nervous System Tissues (1995) (0)
- Creutzfeldt–Jakob Disease (2015) (0)
- Erratum to: Cellular isoform of the prion protein PrPc in human intestinalcell lines: Genetic polymorphism at codon 129, mRNA quantification and protein detection in lipid rafts [30 (6) 559–567] (2008) (0)
- Chapter 10 – Parkinson’s Disease (2015) (0)
- The protein-binding pocket of Botulinum neurotoxin B accommodates a preassembled synaptotagmin / ganglioside complex (2021) (0)
- RETROVIRUS INFECTION OF ENTEROCYTES: DO THEY OR DON'T THEY? (1992) (0)
- Full-length title: Role of SARS-CoV-2 mutations in the evolution of the COVID-19 (2023) (0)
- [Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6]. (1991) (0)
- Morphological alterations associated with HIV infection of CD4 − /GalCer + human intestinal epithelial cells (1996) (0)
- Therapeutic and Vaccine Strategies for Stopping the COVID-19 Pandemic Based on Structural and Molecular Modeling Studies of Virus-Ganglioside Interactions (2021) (0)
- Lipid rafts and human diseases: why we need to target gangliosides. (2023) (0)
- Title: Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) (2016) (0)
- Rare spike E484K-harboring SARS-CoV-2 (2021) (0)
- Molecular landscape of BoNT/B bound to a membrane-inserted synaptotagmin/ganglioside complex (2022) (0)
- Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (alpha, beta, gamma, delta, lambda and mu) : a structural and molecular epidemiology study (2021) (0)
- EPITHELIUM INTESTINAL ET VIH (1992) (0)
- [Suramin induces lysosomal storage disorder in HT29-D4 cells during a mechanism of polarized endocytosis]. (1992) (0)
- Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (from alpha to omicron) : a structural and molecular epidemiology study (2021) (0)
- Subject Index Vol. 7, 2000 (2000) (0)
- Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (alpha, beta, gamma, delta, lambda and µ) : a structural and molecular epidemiology study (2021) (0)
- Total Synthesis of Mololipids: A New Series of Anti‐HIV Moloka′iamine Derivatives. (2001) (0)
- CARBON-13 NMR STUDY OF (1-13C) LABELLED GLUCOSE METABOLISM IN HUMAN ADENOCARCINOMA HT 29 CELLS. (1987) (0)
- Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. (1991) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jacques Fantini?
Jacques Fantini is affiliated with the following schools: